ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

Novartis logo

Novartis

Status

Completed

Conditions

Anemia

Treatments

Drug: Deferasirox

Study type

Observational

Funder types

Industry

Identifiers

NCT00466063
CICL670A2411

Details and patient eligibility

About

This registry will evaluate long-term safety and efficacy of deferasirox in children with transfusional iron overload.

Enrollment

108 patients

Sex

All

Ages

2 to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of transfusion-dependent anemia.
  • History of iron overload

Exclusion criteria

Patients with non-transfusional hemosiderosis.

Other protocol-defined inclusion/exclusion criteria may apply.

Trial design

108 participants in 1 patient group

ICL670
Description:
ICL670
Treatment:
Drug: Deferasirox

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems